Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 09, 2019

SELL
$121.81 - $142.95 $1.21 Million - $1.42 Million
-9,943 Closed
0 $0
Q4 2018

Feb 07, 2019

SELL
$115.94 - $166.74 $5.47 Million - $7.87 Million
-47,197 Reduced 82.6%
9,943 $1.23 Million
Q3 2018

Nov 01, 2018

BUY
$161.01 - $180.57 $13,685 - $15,348
85 Added 0.15%
57,140 $9.61 Million
Q2 2018

Aug 07, 2018

BUY
$146.33 - $183.18 $8.35 Million - $10.5 Million
57,055 New
57,055 $9.83 Million
Q4 2017

Feb 01, 2018

SELL
$131.06 - $150.39 $5.42 Million - $6.22 Million
-41,360 Closed
0 $0
Q3 2017

Nov 01, 2017

BUY
$142.62 - $155.6 $5.9 Million - $6.44 Million
41,360
41,360 $6.05 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.69B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Monarch Partners Asset Management LLC Portfolio

Follow Monarch Partners Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monarch Partners Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monarch Partners Asset Management LLC with notifications on news.